Best of the ACC Scientific Session 2002

Reviews in Cardiovascular Medicine

Volumn 3, Issue 2, 2002, Pages 85-104

  Creager, Mark A ^a   Faxon, David P ^a   Fonarow, Gregg C ^a   Gersh, Bernard J ^a   Holmes Jr , David R ^a   Jacobs, Alice K ^a   Lepor, Norman E ^a   McCullough, Peter A ^a   Prystowsky, Eric N ^a   Vogel, Robert A ^a   Weyman, Arthur E ^a   Weber, Michael A ^a   Yeung, Alan C ^a  

^a NONE

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Adenosine; AFFIRM; Aldosterone; AMIGO; AMISTAD II; Atenolol; Atherosclerosis; AZACS; Azithromycin; B type natriuretic peptide; BNP; COAST; Congestive heart failure; DANAMI 2; ENABLE; Enalapril; Endothelial receptor antagonists; Enoxaparin; Eplerenone; Eptifibatide; Fibrinolysis; First in Man trial; Hypertension; ICDS; Interact; ISAR STEREO; Left ventricular hypertrophy; LIFE; LIPS; Losartan; MADIT II; OVERTURE; Paclitaxel; Patent foramen ovale; PCI; RAVEL; Reperfusion; Sirolimus; Statins; Stents; Stroke; Tacrolimus; Vasopeptidase inhibition; WIZARD

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ANGIOPEPTIN; ANGIOTENSIN 2 RECEPTOR; ANTICOAGULANT AGENT; ANTISENSE OLIGONUCLEOTIDE; ANTITHROMBOCYTIC AGENT; ATENOLOL; BATIMASTAT; DACTINOMYCIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENOXAPARIN; EPLERENONE; EPTIFIBATIDE; FLUINDOSTATIN; HALOFUGINONE; HEPARIN; HYDROCHLOROTHIAZIDE; LOSARTAN; PACLITAXEL; PLACEBO; POLYMER; RAMIPRIL; RAPAMYCIN; SPIRONOLACTONE; TACROLIMUS; TRANILAST; UNINDEXED DRUG;

ADULT; AGED; BLEEDING; BRACHYTHERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PROCEDURES; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DEFIBRILLATOR; DOSE RESPONSE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG RELEASE; DRUG SAFETY; FEASIBILITY STUDY; FIBRIN DEPOSITION; GRAFT REJECTION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; NECROSIS; PHYSICAL CHEMISTRY; RESTENOSIS; STENT; THROMBOSIS;

EID: 0036078279     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. A prospective, blinded trial of B-type natriuretic peptide as a diagnostic test for the emergency diagnosis of heart failure: The Breathing Not Properly (BNP) Multinational Study
2. Efficacy and safety of eplerenone, enalapril, and eplerenone/enalapril combination therapy in patients with left ventricular hypertrophy
3. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomized trial against atenolol
4. Randomized trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack
5. Effects of an angiotensin-converting enzyme inhibitor, ramipril on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
6. The Sixth Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
7. Comparison of medical treatment with percutaneous closure of patent foramen ovale for secondary prevention of TIAs and strokes: A case-control study
8. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary disease
9. Randomized trial of low-molecular-weight heparin (enoxaparin) vs. unfractionated heparin for unstable coronary artery disease: 1-year results of the ESSENCE study
10. The integrilin and enoxaparin randomized assessment of acute coronary syndrome treatment (INTERACT) trial
11. A double-blind, placebo-controlled, randomized trial of fluvastatin after successful percutaneous coronary intervention (PCI) in patients with coronary heart disease: The Lescol Intervention Prevention Study (LIPS)
12. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention
13. Effect of pre-procedure lipid lowering therapy on in-hospital mortality following percutaneous coronary interventions: An analysis of a large multicenter database
14. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
15. OVERTURE: Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events
16. ENABLE: Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure
17. Effect of stent design and strut thickness on long-term outcome of coronary stent placement: Results from the ISAR-STEREO-2 Trial
18. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome
19. Heparin-coated stents in small coronary arteries: Results of the COAST trial
20. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
21. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction
22. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction
23. ST-segment resolution as a tool for assessing the efficacy of reperfusion therapy
24. No-reflow phenomenon
25. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction
26. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: Limitation of myocardial infarction following thrombolysis in infarction (LIMIT AMI) study
27. Defining the role of abciximab for acute coronary syndromes: Lessons from CADILLAC, ADMIRAL, GUSTO IV, GUSTO V, and TARGET
28. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
29. Cardiovascular purinoceptors
30. Ischemic pre-conditioning: From adenosine receptor of KATP channel